Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Centre Oscar Lambret
Pfizer
Bristol-Myers Squibb
AI Labs Group S.L
Adaptimmune
Almirall, S.A.
Bayer
UNC Lineberger Comprehensive Cancer Center
Institut Curie
Anaveon AG
Washington University School of Medicine
Ahvaz Jundishapur University of Medical Sciences
Palleon Pharmaceuticals, Inc.
Sheba Medical Center
Duke University
Verrica Pharmaceuticals Inc.
Scholar Rock, Inc.
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
Tvardi Therapeutics, Incorporated
Cedars-Sinai Medical Center
Altor BioScience
Eli Lilly and Company
RECORDATI GROUP
GlaxoSmithKline
AstraZeneca
National Cancer Institute (NCI)
TuHURA Biosciences, Inc.
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Exelixis
Centre Hospitalier Universitaire de Saint Etienne
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Apexigen America, Inc.
Apexigen America, Inc.
Sumitomo Pharma America, Inc.
Perspective Therapeutics
Novartis
Novo Nordisk A/S
Hoffmann-La Roche
Revolution Medicines, Inc.
National Institutes of Health Clinical Center (CC)
University Hospital Heidelberg